Lasting Changes to Circulating Leukocytes in People with Mild SARS-CoV-2 Infections
暂无分享,去创建一个
Matthew S. Miller | M. Levings | P. Nair | J. Ang | Braeden Cowbrough | D. Bowdish | L. Cook | J. Bramson | James W. Smith | M. Larché | K. Ask | A. McGeer | S. Svenningsen | H. Stacey | B. Coleman | N. Hambly | J. G. Wallace | M. Larché | Kiho Son | Allison E Kennedy | Jessica A. Breznik | A. Huynh | I. Nazy | M. Mukherjee | P. Nair | J. Breznik | K. Son | B. Cowbrough | A. Kennedy
[1] Konrad U. Förstner,et al. 6th European Congress of Immunology, 1-4 September 2021, Virtual meeting. , 2021, European journal of immunology.
[2] X. Mariette,et al. Systemic and organ-specific immune-related manifestations of COVID-19 , 2021, Nature Reviews Rheumatology.
[3] A. Banerjee,et al. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study , 2021, BMJ.
[4] E. Poveda,et al. Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection , 2021, Cellular & Molecular Immunology.
[5] Mario Sansone,et al. Cytokine signature and COVID-19 prediction models in the two waves of pandemics , 2021, Scientific Reports.
[6] Benjamin Bowe,et al. High-dimensional characterization of post-acute sequelae of COVID-19 , 2021, Nature.
[7] A. Banerjee,et al. Epidemiology of post-COVID syndrome following hospitalisation with coronavirus: a retrospective cohort study , 2021, medRxiv.
[8] J. Donnelly,et al. Readmission and Death After Initial Hospital Discharge Among Patients With COVID-19 in a Large Multihospital System. , 2020, JAMA.
[9] R. Alon,et al. Leukocyte trafficking to the lungs and beyond: lessons from influenza for COVID-19 , 2020, Nature reviews. Immunology.
[10] G. Matarese,et al. T Cells: Warriors of SARS-CoV-2 Infection , 2020, Trends in Immunology.
[11] V. Chopra,et al. Sixty-Day Outcomes Among Patients Hospitalized With COVID-19 , 2020, Annals of Internal Medicine.
[12] M. Honigsbaum,et al. Taking pandemic sequelae seriously: from the Russian influenza to COVID-19 long-haulers , 2020, The Lancet.
[13] Steven M. Holland,et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19 , 2020, Science.
[14] J. Greenbaum,et al. Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity , 2020, Cell.
[15] Matthew S. Miller,et al. Characteristics of Anti-SARS-CoV-2 Antibodies in Recovered COVID-19 Subjects , 2020, Viruses.
[16] T. Greenhalgh,et al. Management of post-acute covid-19 in primary care , 2020, BMJ.
[17] H. Prescott,et al. Recovery From Severe COVID-19: Leveraging the Lessons of Survival From Sepsis. , 2020, JAMA.
[18] S. Mallal,et al. Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans , 2020, Science.
[19] Zeyu Chen,et al. T cell responses in patients with COVID-19 , 2020, Nature Reviews Immunology.
[20] Elisabeth Mahase. Covid-19: What do we know about “long covid”? , 2020, BMJ.
[21] M. Evert,et al. Coronavirus disease 2019 induces multi‐lineage, morphologic changes in peripheral blood cells , 2020, EJHaem.
[22] Morten Nielsen,et al. Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19 , 2020, Cell.
[23] M. Mann,et al. Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV , 2020, Nature.
[24] R. Pranata,et al. Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis , 2020, Journal of Intensive Care.
[25] C. Blish,et al. The Innate Immune System: Fighting on the Front Lines or Fanning the Flames of COVID-19? , 2020, Cell Host & Microbe.
[26] Angelo Mazza,et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study , 2020, The Lancet.
[27] Xiaohu Zheng,et al. Effective treatment of severe COVID-19 patients with tocilizumab , 2020, Proceedings of the National Academy of Sciences.
[28] Hong-juan Liu,et al. COVID-19 infection induces readily detectable morphological and inflammation-related phenotypic changes in peripheral blood monocytes, the severity of which correlate with patient outcome , 2020, medRxiv.
[29] Yu Cui,et al. TGF-β signaling controls Foxp3 methylation and T reg cell differentiation by modulating Uhrf1 activity , 2019, The Journal of experimental medicine.
[30] C. Verschoor,et al. A comprehensive assessment of immunophenotyping performed in cryopreserved peripheral whole blood , 2018, Cytometry. Part B, Clinical cytometry.
[31] S. Karampatos,et al. Monocyte activation is elevated in women with knee-osteoarthritis and associated with inflammation, BMI and pain. , 2017, Osteoarthritis and cartilage.
[32] C. Hedrick,et al. Nonclassical patrolling monocyte function in the vasculature. , 2015, Arteriosclerosis, thrombosis, and vascular biology.
[33] Smita Y. Patel,et al. Establishment of a healthy human range for the whole blood “OX40” assay for the detection of antigen‐specific CD4+ T cells by flow cytometry , 2014, Cytometry. Part B, Clinical cytometry.
[34] J. Ananworanich,et al. Human antigen‐specific CD4+CD25+CD134+CD39+ T cells are enriched for regulatory T cells and comprise a substantial proportion of recall responses , 2014, European journal of immunology.
[35] Xiaopei Huang,et al. The Development and Function of Memory Regulatory T Cells after Acute Viral Infections , 2012, The Journal of Immunology.
[36] O. Rotzschke,et al. Influenza A Virus Infection Results in a Robust, Antigen-Responsive, and Widely Disseminated Foxp3+ Regulatory T Cell Response , 2011, Journal of Virology.
[37] Rachel E. Owen,et al. Tregs control the development of symptomatic West Nile virus infection in humans and mice. , 2009, The Journal of clinical investigation.
[38] D. Cooper,et al. High Levels of Human Antigen-Specific CD4+ T Cells in Peripheral Blood Revealed by Stimulated Coexpression of CD25 and CD134 (OX40)1 , 2009, The Journal of Immunology.
[39] A. Cumano,et al. Monitoring of Blood Vessels and Tissues by a Population of Monocytes with Patrolling Behavior , 2007, Science.
[40] P. Greenberg,et al. Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of epitope specificities. , 2007, Blood.
[41] C. Geula,et al. Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease , 2007, Nature Medicine.
[42] T. Springer,et al. Stimulated mobilization of monocyte Mac-1 and p150,95 adhesion proteins from an intracellular vesicular compartment to the cell surface. , 1987, The Journal of clinical investigation.
[43] Qin Ning,et al. Clinical and immunological features of severe and moderate coronavirus disease 2019 , 2020 .
[44] P. Kubes,et al. Monocyte Conversion During Inflammation and Injury. , 2017, Arteriosclerosis, thrombosis, and vascular biology.